Noom vs Fridays: App-Based Care vs Medication-First GLP-1

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This PlexusDx Education Hub comparison sets a behavior-change heritage against a medication-first program and asks what that difference means for GLP-1 care. Browse all Peptides & GLP-1 education

Independent editorial review: PlexusDx has no commercial relationship with Noom, its parent company, or Fridays, and no affiliate compensation is involved in publishing this piece.

Full head-to-head: PlexusDx vs Fridays →

Noom and Fridays approach weight from opposite starting points. Noom built its name on behavior-change coaching and later layered a medication add-on on top; Fridays began as a medication-first program. The philosophy each brand started with still colors how it delivers GLP-1 care today. This review is current as of April 2026.

Behavior change meets medication

The core contrast is heritage. Noom, Inc. grew from a psychology-driven app focused on habits, food logging, and coaching, then introduced a prescription pathway, whereas Fridays Health centered on medication access from the outset. Understanding that origin helps explain where each program invests — behavioral tooling on one side, medication logistics on the other.

Noom's app-first heritage and the medication add-on

Noom operates as an app-based subscription with a medication add-on: users engage the coaching platform, and eligible members can access a provider-issued prescription for FDA-approved brand GLP-1 products or compounded semaglutide and tirzepatide through a licensed pharmacy pathway. Because features and eligibility evolve, confirm current terms on Noom's official website.

Fridays' medication-first structure

Fridays leads with the prescription. Its telehealth plus compounded-pharmacy pathway routes an intake to a licensed clinician and, on eligibility, dispenses compounded medication with coaching and dietitian support included. Program details shift over time, so check the current structure at Fridays's official website.

What each model costs to run

Fridays' pricing is published directly: compounded semaglutide at $249/mo and compounded tirzepatide at $359/mo month-to-month (joinfridays.com/pricing, verified 2026-07-20), with no membership fee, free shipping, coaching, and dietitian support, dropping to roughly $150/mo and $240/mo on a prepaid annual plan. Fridays' rates moved materially within a single day, so verify before you commit. Noom prices its subscription and any medication component separately, so a like-for-like comparison depends on whether you value the coaching layer. For reference, PlexusDx month-to-month runs about $60–$70/mo below Fridays on both compounds, while Fridays' prepaid 3- and 6-month bundles come in lower per month.

The science under the prescriptions

Coaching apps and medication-first programs converge on the same molecules. GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the dual GIP/GLP-1 agonist tirzepatide were tested in STEP (semaglutide, weight management, NEJM 2021), SURMOUNT (tirzepatide, weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide, obstructive sleep apnea, NEJM 2024). Behavioral support can complement the medication, but the pharmacology comes from the compound.

The genetic context both apps leave out

Neither a coaching app nor a medication-first service reads the inherited layer that shapes a GLP-1 response. Variants in FTO (fat-mass and obesity-associated), GLP1R (the gene encoding the GLP-1 receptor), MC4R (a hub for satiety and energy balance), and TCF7L2 (linked to glucose homeostasis and incretin release) chart the metabolic baseline behind any protocol. These pathway-level markers do not predict compound response but do describe your biology. PlexusDx supplies that missing layer: the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights across FTO, MC4R, and TCF7L2, alongside its own Weight Management Protocols — Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. Knowing your baseline first makes the conversation with your provider a grounded one.

No affiliation: PlexusDx is independent of Noom and has no commercial relationship with any company reviewed in this article.

More from the PlexusDx Education Hub: GLP 1 Hormone, What Is GLP 1, GLP 1 What Is, GLP 1 Receptor Agonist.

Editorial disclaimer: this comparison is educational and not a purchase recommendation. PlexusDx is not affiliated with Noom and offers semaglutide and tirzepatide through its own Weight Management Protocols. The Precision Peptide Genetic Test analyzes how genes influence peptide-related pathways and does not predict response to any specific medication. Consult a qualified healthcare provider before starting any peptide protocol.

Consider a medication path with genetics up front: explore the Weight Management Protocols, or begin with the Precision Peptide Genetic Test to understand your GLP-1 pathway first.

Frequently Asked Questions

Does Noom require the coaching app to get medication?

Noom's model is app-first with a medication add-on, so the coaching subscription is central to the experience, and eligible members access a prescription through it. Fridays, by contrast, leads with the medication. Whether the coaching layer is worth the added cost is an individual call — check each brand's current terms.

Which is better value, Noom or Fridays?

Value depends on what you want. If behavior-change coaching is a priority, Noom's app-centered model may justify its structure; if you want direct medication access with pricing spelled out, Fridays' medication-first program is more transparent. Compare total monthly cost and included support on each brand's own site.

Does the Precision Peptide Genetic Test replace behavior coaching?

No. The test does not coach, treat, or predict response to any medication or program. It reads pathway-level variants in FTO and MC4R, and TCF7L2 that describe baseline GLP-1 biology — information that can inform a provider conversation whether or not you also use a behavior-change app.

How does the PlexusDx approach differ from Noom and Fridays?

PlexusDx pairs its own semaglutide and tirzepatide protocols with the Precision Peptide Genetic Test. Instead of a coaching app or a medication-only pathway, it emphasizes pathway-level genetic context on FTO, MC4R — an upstream layer that neither Noom nor Fridays places beside the prescription.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.